The report segments the global immunology market by category (immuno boosters and immune suppressants) and by geography (the Americas, EMEA, and APAC). It provides a detailed illustration of the major factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.
Here are some key findings of the global immunology market, according to Technavio healthcare and life sciences researchers:
- Growing organ transplantation: a major market driver
- In 2017, the immunosuppresants segment dominated the market by occupying almost 60% share
- The Americas dominated the global immunology market with around 40% share in 2017
- AbbVie, Amgen, Angimmune, Bionor Pharma, and Celgene are some of the players in the market
Save more with Technavio. Buy 2 reports and get the third for free: View Technavio’s latest discounts and promotions
Growing organ transplantation: a major market driver
Growing organ transplantation is one of the major factors driving the global immunology market. The rate of organ transplantation has been continuously witnessing a substantial increase from the last few years. The factors that are contributing to the increase in organ transplantations include ongoing commitment and combined efforts of organ procurement organizations, hospitals, and organ procurement and transplantation network (OPTN).
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Americas: largest immunology market
The Americas contributed the maximum share of around 40% to the global immunology market in 2017 owing to the high prevalence of immune-mediated malignancies. In addition, the availability of favorable reimbursement policies and high awareness about immunological products is promoting the growth of the market in this region.
According to a senior analyst at Technavio for research on cardiovascular and metabolic disorders, “The immunology market in the Americas is predicted to register a moderate growth during the forecast period due to the increased funding from government and non-government bodies along with the rise in the prevalence rate of chronic diseases such as rheumatoid arthritis and cancer.”
Competitive vendor landscape
The global immunology market is expected to witness an intense competition among vendors due to the adoption of disruptive strategies for sustaining in the competitive environment. Extensive product development activities, enhancements of distribution channels, and efforts in the direction of regional expansion are increasing from the operating vendors in the global immunology market.
Get a sample copy of the global immunology market report free of cost
Access Technavio’s continuously growing cardiovascular and metabolic disorders research library and find expert analysis on hundreds of markets.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.